These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17188301)

  • 1. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in multiple sclerosis: should clinicians trust proxy ratings?
    Tripoliti E; Campbell C; Pring T; Taylor-Goh S
    Mult Scler; 2007 Nov; 13(9):1190-4. PubMed ID: 17623731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.
    Alshubaili AF; Ohaeri JU; Awadalla AW; Mabrouk AA
    BMC Health Serv Res; 2008 Oct; 8():206. PubMed ID: 18840287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
    Montel SR; Bungener C
    Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.
    Patti F; Pozzilli C; Montanari E; Pappalardo A; Piazza L; Levi A; Onesti E; Pesci I;
    Mult Scler; 2007 Jul; 13(6):783-91. PubMed ID: 17613607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
    Pappalardo A; Patti F
    Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Searching for more specific dimensions for the measurement of quality of life in multiple sclerosis].
    Rivera-Navarro J; Benito-León J; Morales-González JM
    Rev Neurol; 2001 Apr 16-30; 32(8):705-13. PubMed ID: 11391503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Acaster S; Swinburn P; Wang C; Stemper B; Beckmann K; Knappertz V; Pohl C; Sandbrink R; Gondek K; Edan G; Kappos L; Freedman M; Hartung HP; Arnason B; Comi G; Filippi M; Jeffery D; O'Connor P; Cook S; Lloyd AJ
    Mult Scler; 2011 Dec; 17(12):1504-13. PubMed ID: 21757536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
    Sharafaddinzadeh N; Moghtaderi A; Kashipazha D; Majdinasab N; Shalbafan B
    Mult Scler; 2010 Aug; 16(8):964-9. PubMed ID: 20534644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in multiple sclerosis patients in Spain.
    Chang CH; Cella D; Fernández O; Luque G; de Castro P; de Andrés C; Casanova B; Hernández MA; Prieto JM; Fernández VE; de Ramón E;
    Mult Scler; 2002 Dec; 8(6):527-31. PubMed ID: 12474996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
    J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Arch Neurol; 2004 May; 61(5):679-86. PubMed ID: 15148144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian.
    Füvesi J; Bencsik K; Benedek K; Mátyás K; Mészáros E; Rajda C; Losonczi E; Fricska-Nagy Z; Vécsei L
    Mult Scler; 2008 Apr; 14(3):391-8. PubMed ID: 18208896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Italian version of the Neck Pain and Disability Scale, NPDS-I: cross-cultural adaptation, reliability, and validity.
    Monticone M; Baiardi P; Nido N; Righini C; Tomba A; Giovanazzi E
    Spine (Phila Pa 1976); 2008 Jun; 33(13):E429-34. PubMed ID: 18520930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.